Discover the detailed record of transactions filed by THEUER CHARLES, Chairman & CEO. Insider active across 1 companies, notably Tracon Pharmaceuticals, Inc.. In total, 13 reports have been published. Total volume traded: €86k. The latest transaction was filed on 9 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Charles Theuer is the Chairman and CEO of Tracon Pharmaceuticals, Inc. He leads the company in the development of innovative cancer treatments. Under his leadership, Tracon aims to improve patient outcomes through targeted therapies. Charles Theuer has extensive experience in the pharmaceutical sector, contributing to the company's strategy and vision.